Study: NCT00811993

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RG1507
Description: Starting dose of \>=3mg/kg iv escalating to a maximum dose of \<=16mg/kg iv, depending on dosing schedule in each combination treatment arm

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RG1507
Description: Starting dose of \>=3mg/kg iv escalating to a maximum dose of \<=16mg/kg iv, depending on dosing schedule in each combination treatment arm

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RG1507
Description: Starting dose of \>=3mg/kg iv escalating to a maximum dose of \<=16mg/kg iv, depending on dosing schedule in each combination treatment arm

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RG1507
Description: Starting dose of \>=3mg/kg iv escalating to a maximum dose of \<=16mg/kg iv, depending on dosing schedule in each combination treatment arm

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RG1507
Description: Starting dose of \>=3mg/kg iv escalating to a maximum dose of \<=16mg/kg iv, depending on dosing schedule in each combination treatment arm

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RO1507
Description: 27mg/kg iv, monotherapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bevacizumab [Avastin]
Description: as prescribed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bevacizumab [Avastin]
Description: as prescribed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bevacizumab [Avastin]
Description: as prescribed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bevacizumab [Avastin]
Description: as prescribed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bevacizumab [Avastin]
Description: as prescribed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: capecitabine [Xeloda]
Description: as prescribed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carboplatin
Description: as prescribed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carboplatin
Description: as prescribed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cetuximab
Description: as prescribed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: docetaxel
Description: as prescribed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: erlotinib [Tarceva]
Description: as prescribed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: erlotinib [Tarceva]
Description: as prescribed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: etoposide
Description: as prescribed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gemcitabine
Description: as prescribed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: irinotecan
Description: as prescribed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mFOLFOX6
Description: as prescribed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: paclitaxel
Description: as prescribed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: paclitaxel
Description: as prescribed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pemetrexel
Description: as prescribed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sorafenib
Description: as prescribed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: temozolomide
Description: as prescribed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: trastuzumab [Herceptin]
Description: as prescribed